Literature DB >> 17848164

Human dendritic cells transfected with allergen-DNA stimulate specific immunoglobulin G4 but not specific immunoglobulin E production of autologous B cells from atopic individuals in vitro.

Bettina König1, Arnd Petersen, Iris Bellinghausen, Ingo Böttcher, Wolf-Meinhard Becker, Jürgen Knop, Joachim Saloga.   

Abstract

Atopic/allergic diseases are characterized by T helper 2 (Th2)-dominated immune responses resulting in immunoglobulin E (IgE) production. DNA-based immunotherapies have been shown to shift the immune response towards Th1 in animal models. In further studies we showed that human dendritic cells (DC) transfected with allergen-DNA are able to stimulate autologous CD4(+) T cells from atopic individuals to produce Th1 instead of Th2 cytokines and to activate interferon-gamma (IFN-gamma)-producing CD8(+) T cells. The aim of this study was to analyse whether DC transfected with allergen-DNA are also able to influence immunoglobulin production of B cells from atopic donors. For this purpose, human monocyte-derived DC from grass-pollen allergic donors were transfected with an adenovirus encoding the allergen Phleum pratense 1 and cocultured with B cells, autologous CD4(+) T cells, and CD40 ligand-transfected L-cells. B cells receiving help from CD4(+) T cells stimulated with allergen-transfected dendritic cells produced more allergen-specific IgG4 compared to stimulation with allergen protein pulsed DC or medium, while total IgG4 production was not affected. In contrast, specific IgE production was not enhanced by stimulation with allergen-DNA transfected DC compared to medium and inhibited compared to allergen protein-pulsed DC with similar effects on total IgE production in vitro. Allergen-DNA transfected dendritic cells are able to direct the human allergic immune response from Th2-dominance towards Th1 and Tc1 also resulting in decreased IgE and increased IgG4 production.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17848164      PMCID: PMC2266010          DOI: 10.1111/j.1365-2567.2007.02633.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  39 in total

1.  The influence of CpG motifs on a protein or DNA-based Th2-type immune response against major pollen allergens Bet v 1a, Phl p 2 and Escherichia coli-derived beta-galactosidase.

Authors:  R Hochreiter; A Hartl; J Freund; R Valenta; F Ferreira; J Thalhamer
Journal:  Int Arch Allergy Immunol       Date:  2001 Jan-Mar       Impact factor: 2.749

Review 2.  Designing immune responses with genetic immunization and immunostimulatory DNA sequences.

Authors:  J Thalhamer; W Leitner; P Hammerl; J Brtko
Journal:  Endocr Regul       Date:  2001-09

3.  In vivo transfection and/or cross-priming of dendritic cells following DNA and adenoviral immunizations for immunotherapy of cancer--changes in peripheral mononuclear subsets and intracellular IL-4 and IFN-gamma lymphokine profile.

Authors:  M Mincheff; I Altankova; S Zoubak; S Tchakarov; C Botev; S Petrov; E Krusteva; G Kurteva; P Kurtev; V Dimitrov; M Ilieva; G Georgiev; T Lissitchkov; I Chernozemski; H T Meryman
Journal:  Crit Rev Oncol Hematol       Date:  2001 Jul-Aug       Impact factor: 6.312

4.  Structural investigations of the major allergen Phl p I on the complementary DNA and protein level.

Authors:  A Petersen; G Schramm; A Bufe; M Schlaak; W M Becker
Journal:  J Allergy Clin Immunol       Date:  1995-05       Impact factor: 10.793

5.  Regulation of IgE and IgG4 responses by allergen specific T-cell clones to bee venom phospholipase A2 in vitro.

Authors:  J M Carballido; N Carballido-Perrig; A Oberli-Schrämmli; C H Heusser; K Blaser
Journal:  J Allergy Clin Immunol       Date:  1994-04       Impact factor: 10.793

6.  Immunoprophylaxis of allergen-induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization.

Authors:  C H Hsu; K Y Chua; M H Tao; Y L Lai; H D Wu; S K Huang; K H Hsieh
Journal:  Nat Med       Date:  1996-05       Impact factor: 53.440

7.  Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector.

Authors:  V Juillard; P Villefroy; D Godfrin; A Pavirani; A Venet; J G Guillet
Journal:  Eur J Immunol       Date:  1995-12       Impact factor: 5.532

8.  Isoforms of the major allergen of birch pollen induce different immune responses after genetic immunization.

Authors:  A Hartl; J Kiesslich; R Weiss; A Bernhaupt; S Mostböck; S Scheiblhofer; H Flöckner; M Sippl; C Ebner; F Ferreira; J Thalhamer
Journal:  Int Arch Allergy Immunol       Date:  1999-09       Impact factor: 2.749

9.  Efficacy of recombinant adenovirus as vector for allergen gene therapy in a mouse model of type I allergy.

Authors:  S Sudowe; E Montermann; J Steitz; T Tüting; J Knop; A B Reske-Kunz
Journal:  Gene Ther       Date:  2002-01       Impact factor: 5.250

10.  Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization.

Authors:  E Raz; H Tighe; Y Sato; M Corr; J A Dudler; M Roman; S L Swain; H L Spiegelberg; D A Carson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.